Amgen AMGN
SEC filings (XBRL) · quarterly · fiscal year ends December 31
Pick a second metric to compare.
Source: SEC EDGAR 10-Q/10-K XBRL, CIK 318154; every value is traced to its filing on EDGAR. Retrieved Oct 11, 2026. Quarters labelled by fiscal quarter with the calendar period end. Q4 = annual minus Q1–Q3; cash-flow quarters derived from year-to-date figures.
Last 84 quarters
| Q3 2024Sep 30, 2024 | Q4 2024Dec 31, 2024 | Q1 2025Mar 31, 2025 | Q2 2025Jun 30, 2025 | Q3 2025Sep 30, 2025 | Q4 2025Dec 31, 2025 | Q1 2026Mar 31, 2026 | Q2 2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5B | $9.1B | $8.1B | $9.2B | $9.6B | $9.9B | $8.6B | $10.1B |
| Operating income | $2.0B | $2.3B | $1.2B | $2.7B | $2.5B | $2.7B | $2.7B | $3.5B |
| Net income | $2.8B | $0.6B | $1.7B | $1.4B | $3.2B | $1.3B | $1.8B | $2.4B |
| Capital spending | $0.3B | $0.4B | $0.4B | $0.4B | $0.4B | $0.6B | $0.7B | $0.5B |
| Operating cash flow | $3.6B | $4.8B | $1.4B | $2.3B | $4.7B | $1.6B | $2.2B | $4.0B |
| Free cash flow | $3.3B | $4.4B | $1.0B | $1.9B | $4.2B | $1.0B | $1.5B | $3.5B |
| Capex / operating cash flow | 7.2% | 7.8% | 29.6% | 16.2% | 9.3% | 40.0% | 32.5% | 12.8% |
| Shares outstanding | 537.5M | 537.2M | 537.7M | 538.4M | 538.5M | 539.1M | 539.7M | 540.6M |
| Share count change, y/y | +0.4% | +0.2% | +0.2% | +0.2% | +0.2% | +0.3% | +0.4% | +0.4% |
| Diluted shares (weighted avg.) | 542.0M | — No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | 541.0M | 541.0M | 542.0M | — No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | 544.0M | 544.0M |
— Diluted shares (weighted avg.): No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
— Diluted shares (weighted avg.): No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
Diluted shares (weighted avg.): fiscal Q4 is blank because the 10-K gives 12-month figures only.
XBRL tags used
| Revenue | Revenues | Mar 2017 to Jun 2020 |
|---|---|---|
RevenueFromContractWithCustomerExcludingAssessedTax | Sep 2020 to Jun 2026 | |
| Operating income | OperatingIncomeLoss | Mar 2017 to Jun 2026 |
| Net income | NetIncomeLoss | Mar 2017 to Jun 2026 |
| Capital spending | PaymentsToAcquirePropertyPlantAndEquipment | Mar 2017 to Jun 2026 |
| Operating cash flow | NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Free cash flow | ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment | Mar 2017 to Jun 2026 |
| Capex / operating cash flow | capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Shares outstanding | dei:EntityCommonStockSharesOutstanding | Mar 2017 to Jun 2026 |
| Diluted shares (weighted avg.) | WeightedAverageNumberOfDilutedSharesOutstanding | Mar 2017 to Jun 2026 |
Where a company changed tags, each quarter uses the tag it was reported under; the newest tag is primary.